
Administration Looks to Restrict Junk Plans
Last week, the Biden-Harris administration released a proposed rule that would limit the sale of short-term, limited-duration insurance (STLDI) or
Join Us Live for a Discussion on Medicare, Democracy, and the Future of Health Care
Medicare Watch articles are featured in Medicare Rights’ weekly newsletter, which helps readers stay updated on Medicare policy and advocacy developments and learn about changes in Medicare benefits and rules. Subscribe now by visiting www.medicarerights.org/newsletters.

Last week, the Biden-Harris administration released a proposed rule that would limit the sale of short-term, limited-duration insurance (STLDI) or

The Inflation Reduction Act (IRA) made key changes to improve prescription drug affordability for people with Medicare. Important reforms that

The Inflation Reduction Act (IRA) capped out-of-pocket costs for insulin medications for people with Medicare. Coinsurances and copays for insulin

This week, the Centers for Medicare & Medicaid Services (CMS) released two new data tools as part of the Biden-Harris

Late last month, the U.S. Department of Health and Human Services Office of Inspector General (OIG) released a report finding

During most of the COVID-19 pandemic, states were allowed to keep people continuously enrolled in Medicaid in exchange for enhanced

For many low-income Medicare beneficiaries, the Part D Low-Income Subsidy (LIS) program (also called “Extra Help”) can be a lifeline,

Heat can be hazardous, leading to more deaths than any other weather-related phenomenon. While some parts of the U.S. are

The end of continuous Medicaid enrollment due to COVID-19 is projected to cause significant coverage losses nationally as states recertify

This week, the pharmaceutical giant Merck sued the U.S. Department of Health and Human Services (HHS), challenging Medicare’s authority to

Last week, the Biden-Harris administration released a proposed rule that would limit the sale of short-term, limited-duration insurance (STLDI) or

The Inflation Reduction Act (IRA) made key changes to improve prescription drug affordability for people with Medicare. Important reforms that

The Inflation Reduction Act (IRA) capped out-of-pocket costs for insulin medications for people with Medicare. Coinsurances and copays for insulin

This week, the Centers for Medicare & Medicaid Services (CMS) released two new data tools as part of the Biden-Harris

Late last month, the U.S. Department of Health and Human Services Office of Inspector General (OIG) released a report finding

During most of the COVID-19 pandemic, states were allowed to keep people continuously enrolled in Medicaid in exchange for enhanced

For many low-income Medicare beneficiaries, the Part D Low-Income Subsidy (LIS) program (also called “Extra Help”) can be a lifeline,

Heat can be hazardous, leading to more deaths than any other weather-related phenomenon. While some parts of the U.S. are

The end of continuous Medicaid enrollment due to COVID-19 is projected to cause significant coverage losses nationally as states recertify

This week, the pharmaceutical giant Merck sued the U.S. Department of Health and Human Services (HHS), challenging Medicare’s authority to